These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7559018)

  • 1. AHI perspectives: flexible drug labeling and its impact on the drug development process. Practicality of clinical development.
    Copeland DD
    J Am Vet Med Assoc; 1995 Oct; 207(7):895-6; discussion 902-4. PubMed ID: 7559018
    [No Abstract]   [Full Text] [Related]  

  • 2. AHI perspectives: flexible drug labeling and its impact on the drug development process. A clinical pharmacologist's perspective.
    Ter Hune TN
    J Am Vet Med Assoc; 1995 Oct; 207(7):898; discussion 902-4. PubMed ID: 7559020
    [No Abstract]   [Full Text] [Related]  

  • 3. AHI perspectives: flexible drug labeling and its impact on the drug development process. Liability issues.
    Thomas JW
    J Am Vet Med Assoc; 1995 Oct; 207(7):899-900; discussion 902-4. PubMed ID: 7559021
    [No Abstract]   [Full Text] [Related]  

  • 4. AHI perspectives: flexible drug labeling and its impact on the drug development process. In vitro microbiological aspects of flexible labeling.
    Watts JL
    J Am Vet Med Assoc; 1995 Oct; 207(7):896-7; discussion 902-4. PubMed ID: 7559019
    [No Abstract]   [Full Text] [Related]  

  • 5. AHI perspectives: flexible drug labeling and its impact on the drug development process. Practical aspects of flexible labeling in feedlots.
    Apley MD
    J Am Vet Med Assoc; 1995 Oct; 207(7):901-2; discussion 902-4. PubMed ID: 7559022
    [No Abstract]   [Full Text] [Related]  

  • 6. AHI perspectives: flexible drug labeling and its impact on the drug development process. Break-out session.
    J Am Vet Med Assoc; 1995 Oct; 207(7):905-8; discussion 909-10. PubMed ID: 7559023
    [No Abstract]   [Full Text] [Related]  

  • 7. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Bovine Practitioners (AABP).
    Riddell MG
    J Am Vet Med Assoc; 1995 Oct; 207(7):882-3; discussion 890-4. PubMed ID: 7559013
    [No Abstract]   [Full Text] [Related]  

  • 8. American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part I.
    Koritz GD
    J Am Vet Med Assoc; 1995 Oct; 207(7):875-6. PubMed ID: 7559009
    [No Abstract]   [Full Text] [Related]  

  • 9. American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part II.
    Riviere JE
    J Am Vet Med Assoc; 1995 Oct; 207(7):876-8. PubMed ID: 7559010
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward responsible use of the proper dosage of veterinary drugs.
    Powers TE; Powers JD; Varma KJ
    J Am Vet Med Assoc; 1988 Jan; 192(2):250-5. PubMed ID: 3280536
    [No Abstract]   [Full Text] [Related]  

  • 11. Article IV: clinical application of pharmacokinetics.
    Martinez MN
    J Am Vet Med Assoc; 1998 Nov; 213(10):1418-20. PubMed ID: 9828932
    [No Abstract]   [Full Text] [Related]  

  • 12. The contribution of clinical pharmacology to new drug approvals.
    Brown SA
    J Am Vet Med Assoc; 1993 May; 202(10):1700-2;discussion 1713-7. PubMed ID: 8514588
    [No Abstract]   [Full Text] [Related]  

  • 13. [General and special problems concerning the approval and re-evaluation of antimicrobial agents for use in agriculturally useful animals].
    Hoffmann B
    Tierarztl Prax; 1988; 16(2):103-7. PubMed ID: 3047907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Animal Hospital Association (AAHA).
    Reid J
    J Am Vet Med Assoc; 1995 Oct; 207(7):879-80; discussion 890-4. PubMed ID: 7559011
    [No Abstract]   [Full Text] [Related]  

  • 15. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Avian Pathologists (AAAP).
    Wages DP
    J Am Vet Med Assoc; 1995 Oct; 207(7):880-1; discussion 890-4. PubMed ID: 7559012
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M
    Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of the first interactive workshop on professional flexible labeling. The Center for Veterinary Medicine perspective.
    Sundlof SF
    J Am Vet Med Assoc; 1995 Oct; 207(7):867-8. PubMed ID: 7559006
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling.
    Robinson DS
    Psychopharmacol Bull; 1994; 30(1):23-5. PubMed ID: 7972625
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of the first interactive workshop on professional flexible labeling. An Animal Health Institute perspective.
    Farho CJ
    J Am Vet Med Assoc; 1995 Oct; 207(7):869-71. PubMed ID: 7559007
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of the first interactive workshop on professional flexible labeling. An American Veterinary Medical Association perspective.
    Papich MG
    J Am Vet Med Assoc; 1995 Oct; 207(7):871-4. PubMed ID: 7559008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.